Maria J. Ribal (@mariajribal) 's Twitter Profile
Maria J. Ribal

@mariajribal

Head of Uro-Oncology Unit. @hospitalclinic. Chair of #eauguidelines Office uroweb.org/guidelines In love with Urology!! Passion for life!!!

ID: 2524784408

linkhttp://www.urologiaserrateribal.com/ calendar_today26-05-2014 11:14:03

15,15K Tweet

9,9K Followers

2,2K Following

Maria J. Ribal (@mariajribal) 's Twitter Profile Photo

10 years ago, under the vision of James N'Dow, we set out to bring #EAUGuidelines to #socialmedia . It started with a small group, driven by the belief that guidelines become truly valuable when they are shared, discussed, and used together. Leading that first Dissemination

10 years ago, under the vision of <a href="/NDowJames/">James N'Dow</a>, we set out to bring #EAUGuidelines to #socialmedia .
It started with a small group, driven by the belief that guidelines become truly valuable when they are shared, discussed, and used together.
Leading that first Dissemination
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

U.S. FDA approves durvalumab for perioperative immunotherapy for patients with muscle-invasive bladder cancer In a prespecified analysis, the trial demonstrated a statistically significant improvement in event-free survival and overall survival. American Cancer Society Suresh S. Ramalingam, MD, FASCO

<a href="/US_FDA/">U.S. FDA</a>  approves durvalumab for perioperative immunotherapy for patients with muscle-invasive bladder cancer
In a prespecified analysis, the trial demonstrated a statistically significant improvement in event-free survival and overall survival.
<a href="/AmericanCancer/">American Cancer Society</a> <a href="/RamalingamMD/">Suresh S. Ramalingam, MD, FASCO</a>
Dra. María Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile Photo

💫🌟🎯 Long-term surveillance in young adult cancer survivors 📌 Egger-Heidrich et al. | Cancer Treatment Reviews, 2025 💥 “Survival is not enough — thriving requires tailored follow-up.” Cancers MDPI OncoAlert 🔎 Key insights: ✔️YACS face unique risks: SMN, cardiotoxicity,

💫🌟🎯 Long-term surveillance in young adult cancer survivors
📌 Egger-Heidrich et al. | Cancer Treatment Reviews, 2025
💥 “Survival is not enough — thriving requires tailored follow-up.”
<a href="/Cancers_MDPI/">Cancers MDPI</a> <a href="/OncoAlert/">OncoAlert</a>
🔎 Key insights:
✔️YACS face unique risks: SMN, cardiotoxicity,
Hospital Clínic (@hospitalclinic) 's Twitter Profile Photo

🎓 Nova Càtedra UB BCLC per impulsar el coneixement i la prevenció del #càncer de fetge 🔬 Neix amb l’objectiu de traslladar a la societat els coneixements actuals de la malaltia i presentar els reptes que hi ha per millorar-ne l’atenció, la innovació i la #investigació ➕ Info

🎓 Nova Càtedra UB BCLC per impulsar el coneixement i la prevenció del #càncer de fetge

🔬 Neix amb l’objectiu de traslladar a la societat els coneixements actuals de la malaltia i presentar els reptes que hi ha per millorar-ne l’atenció, la innovació i la #investigació

➕ Info
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to Stephen Freedland, MD neal shore & team! Earlier enza works better! Link👉 rb.gy/iyc3f2 OncoAlert UroToday.com Prostate Cancer Foundation

Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to <a href="/SFreedlandMD/">Stephen Freedland, MD</a> <a href="/nealshore/">neal shore</a> &amp; team! Earlier enza works better! Link👉 rb.gy/iyc3f2 <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> <a href="/PCFnews/">Prostate Cancer Foundation</a>
European Urology (@euplatinum) 's Twitter Profile Photo

🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘 🔍 Covering: ✅ State-of-the-art imaging (US, low-dose CT) ✅ MET, ESWL, URS, PCNL ✅ Genetic testing in high-risk patients ✅ Personalized treatment pathways ✅ Practical

🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘

🔍 Covering:
✅ State-of-the-art imaging (US, low-dose CT)
✅ MET, ESWL, URS, PCNL
✅ Genetic testing in high-risk patients
✅ Personalized treatment pathways
✅ Practical
Maria J. Ribal (@mariajribal) 's Twitter Profile Photo

Felicitats a la Dra. Maria Reig Maria Reig per liderar una iniciativa clau des del coneixement, la visió i el compromís. Reconeixement, lideratge clínic i mirada estratègica són més necessaris que mai per construir el futur que volem. Orgullosa de compartir camí amb companyes que

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Just came online in The Lancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh Prostate Cancer Foundation UroToday.com OncoAlert

Just came online in <a href="/TheLancet/">The Lancet</a> 👉Our two papers on improved OS  with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer &amp; HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh <a href="/PCFnews/">Prostate Cancer Foundation</a> <a href="/urotoday/">UroToday.com</a> <a href="/OncoAlert/">OncoAlert</a>
Maria J. Ribal (@mariajribal) 's Twitter Profile Photo

Feet on the desk!! ( such a long time now…🧐🧐) it’s that time again ☀️ Time to unplug, reconnect with nature and (hopefully) recharge. Wishing you all a peaceful summer off!! And 🙏🏻🙏🏻🙏🏻. may the second half of the year be gentler, brighter, and full of purpose. #SummerBreak

Feet on the desk!!  ( such a long time now…🧐🧐) it’s that time again ☀️
Time to unplug, reconnect with nature and (hopefully) recharge.

Wishing you all a peaceful summer off!! And 🙏🏻🙏🏻🙏🏻. may the second half of the year be gentler, brighter, and full of purpose.

#SummerBreak
Andrea Necchi (@andreanecchi) 's Twitter Profile Photo

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

Pippa Sangster (@pippa_sangster) 's Twitter Profile Photo

Strong Andrology girl power publication w amazing @UCLH team … rdcu.be/exM9W Patient satisfaction in priapism patients with penile implants, excellent article to help counsel patients in a difficult setting Izzie Dighero Aisling Looney Chloe Mount Fiona Holden

Strong Andrology girl power publication w amazing @UCLH team … rdcu.be/exM9W Patient satisfaction in priapism patients with penile implants, excellent article to help counsel patients in a difficult setting  <a href="/isabeldijeroo/">Izzie Dighero</a> <a href="/aislinglooney/">Aisling Looney</a> <a href="/chloemount/">Chloe Mount</a> <a href="/fionaholdenuclh/">Fiona Holden</a>